Spitting image: can saliva biomarkers reflect Alzheimer's disease?

od Ashton, Nicholas J., Blennow, Kaj, Zetterberg, Henrik
Wydane w EBioMedicine (2021)

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

od Ashton, Nicholas J., Ide, Mark, Zetterberg, Henrik, Blennow, Kaj
Wydane w Neurol Ther (2019)

Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre‐analytical conditions

od Simrén, Joel, Ashton, Nicholas J., Blennow, Kaj, Zetterberg, Henrik
Wydane w Alzheimers Dement (Amst) (2021)

In vivo Detection of Alzheimer’s Disease

od Leuzy, Antoine, Heurling, Kerstin, Ashton, Nicholas J., Schöll, Michael, Zimmer, Eduardo R.
Wydane w Yale J Biol Med (2018)

Biomarkers for tau pathology

od Schöll, Michael, Maass, Anne, Mattsson, Niklas, Ashton, Nicholas J., Blennow, Kaj, Zetterberg, Henrik, Jagust, William
Wydane w Mol Cell Neurosci (2019)

Fluid Biomarkers for Synaptic Dysfunction and Loss

od Camporesi, Elena, Nilsson, Johanna, Brinkmalm, Ann, Becker, Bruno, Ashton, Nicholas J, Blennow, Kaj, Zetterberg, Henrik
Wydane w Biomark Insights (2020)

Proteomic blood profiling in mild, severe and critical COVID-19 patients

od Patel, Hamel, Ashton, Nicholas J., Dobson, Richard J. B., Andersson, Lars-Magnus, Yilmaz, Aylin, Blennow, Kaj, Gisslen, Magnus, Zetterberg, Henrik
Wydane w Sci Rep (2021)

Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays

od Öhrfelt, Annika, Dumurgier, Julien, Zetterberg, Henrik, Vrillon, Agathe, Ashton, Nicholas J., Kvartsberg, Hlin, Bouaziz-Amar, Elodie, Hugon, Jacques, Paquet, Claire, Blennow, Kaj
Wydane w Alzheimers Res Ther (2020)

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population

od Gleerup, Helena Sophia, Sanna, Federica, Høgh, Peter, Simrén, Joel, Blennow, Kaj, Zetterberg, Henrik, Hasselbalch, Steen Gregers, Ashton, Nicholas J., Simonsen, Anja Hviid
Wydane w Front Aging Neurosci (2021)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease

od Nilsson, Johanna, Gobom, Johan, Sjödin, Simon, Brinkmalm, Gunnar, Ashton, Nicholas J., Svensson, Johan, Johansson, Per, Portelius, Erik, Zetterberg, Henrik, Blennow, Kaj, Brinkmalm, Ann
Wydane w Alzheimers Dement (Amst) (2021)

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease

od Moscoso, Alexis, Grothe, Michel J., Ashton, Nicholas J., Karikari, Thomas K., Lantero Rodríguez, Juan, Snellman, Anniina, Suárez-Calvet, Marc, Blennow, Kaj, Zetterberg, Henrik, Schöll, Michael
Wydane w JAMA Neurol (2021)

Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum

od Moscoso, Alexis, Grothe, Michel J, Ashton, Nicholas J, Karikari, Thomas K, Rodriguez, Juan Lantero, Snellman, Anniina, Suárez-Calvet, Marc, Zetterberg, Henrik, Blennow, Kaj, Schöll, Michael
Wydane w Brain (2020)

Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up

od Kanberg, Nelly, Simrén, Joel, Edén, Arvid, Andersson, Lars-Magnus, Nilsson, Staffan, Ashton, Nicholas J., Sundvall, Pär-Daniel, Nellgård, Bengt, Blennow, Kaj, Zetterberg, Henrik, Gisslén, Magnus
Wydane w EBioMedicine (2021)

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration

od Ashton, Nicholas J., Leuzy, Antoine, Lim, Yau Mun, Troakes, Claire, Hortobágyi, Tibor, Höglund, Kina, Aarsland, Dag, Lovestone, Simon, Schöll, Michael, Blennow, Kaj, Zetterberg, Henrik, Hye, Abdul
Wydane w Acta Neuropathol Commun (2019)

Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline

od Lantero Rodriguez, Juan, Karikari, Thomas K., Suárez-Calvet, Marc, Troakes, Claire, King, Andrew, Emersic, Andreja, Aarsland, Dag, Hye, Abdul, Zetterberg, Henrik, Blennow, Kaj, Ashton, Nicholas J.
Wydane w Acta Neuropathol (2020)

Effects of pre‐analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration

od Ashton, Nicholas J., Suárez‐Calvet, Marc, Karikari, Thomas K., Lantero‐Rodriguez, Juan, Snellman, Anniina, Sauer, Mathias, Simrén, Joel, Minguillon, Carolina, Fauria, Karine, Blennow, Kaj, Zetterberg, Henrik
Wydane w Alzheimers Dement (Amst) (2021)

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative

od Zettergren, Anna, Lord, Jodie, Ashton, Nicholas J., Benedet, Andrea L., Karikari, Thomas K., Lantero Rodriguez, Juan, Snellman, Anniina, Suárez-Calvet, Marc, Proitsi, Petroula, Zetterberg, Henrik, Blennow, Kaj
Wydane w Alzheimers Res Ther (2021)

Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial

od Wihersaari, Lauri, Ashton, Nicholas J., Reinikainen, Matti, Jakkula, Pekka, Pettilä, Ville, Hästbacka, Johanna, Tiainen, Marjaana, Loisa, Pekka, Friberg, Hans, Cronberg, Tobias, Blennow, Kaj, Zetterberg, Henrik, Skrifvars, Markus B.
Wydane w Intensive Care Med (2020)

Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults

od Huebschmann, Nathan A., Luoto, Teemu M., Karr, Justin E., Berghem, Ksenia, Blennow, Kaj, Zetterberg, Henrik, Ashton, Nicholas J., Simrén, Joel, Posti, Jussi P., Gill, Jessica M., Iverson, Grant L.
Wydane w Front Neurol (2020)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease

od Startin, Carla M., Ashton, Nicholas J., Hamburg, Sarah, Hithersay, Rosalyn, Wiseman, Frances K., Mok, Kin Y., Hardy, John, Lleó, Alberto, Lovestone, Simon, Parnetti, Lucilla, Zetterberg, Henrik, Hye, Abdul, Strydom, André
Wydane w Alzheimers Res Ther (2019)